RXD vs. FTXH
RXD (ProShares UltraShort Health Care) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both exchange-traded funds - RXD is a Leveraged Equities fund tracking the DJ Global United States (All) / Health Care -IND (-200%), while FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past 5 years, RXD returned -7.99%/yr vs 8.33%/yr for FTXH. At a correlation of -0.70, they often move in opposite directions. RXD charges 0.95%/yr vs 0.60%/yr for FTXH.
Performance
RXD vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a 4.25% return, which is significantly lower than FTXH's 7.62% return.
RXD
- 1D
- -5.76%
- 1M
- -8.56%
- YTD
- 4.25%
- 6M
- 2.28%
- 1Y
- -22.97%
- 3Y*
- -6.72%
- 5Y*
- -7.99%
- 10Y*
- -19.08%
FTXH
- 1D
- 2.50%
- 1M
- 3.66%
- YTD
- 7.62%
- 6M
- 9.20%
- 1Y
- 39.54%
- 3Y*
- 12.33%
- 5Y*
- 8.33%
- 10Y*
- —
RXD vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | 4.25% | -21.66% | 4.83% | 3.25% | 1.20% | -37.97% | -44.25% | -32.44% | -14.33% | -35.24% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 7.62% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
Correlation
The correlation between RXD and FTXH is -0.85, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.81 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2016 | -0.70 |
The correlation between RXD and FTXH shifts across timeframes, from -0.85 (1 year) to -0.70 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. FTXH — Risk / Return Rank
RXD
FTXH
RXD vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RXD | FTXH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.08 | ||
| Sortino ratioReturn per unit of downside risk | -4.33 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.39 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 5.32 | -5.98 |
| Martin ratioReturn relative to average drawdown | -1.04 | 15.35 | -16.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RXD | FTXH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.77 | 2.32 | -3.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | 0.51 | -0.78 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.58 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.65 | 0.39 | -1.04 |
Drawdowns
RXD vs. FTXH - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.65%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for RXD and FTXH.
Loading charts...
Drawdown Indicators
| RXD | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -32.11% | -67.54% |
Max Drawdown (1Y)Largest decline over 1 year | -34.63% | -7.47% | -27.16% |
Max Drawdown (3Y)Largest decline over 3 years | -36.60% | -19.51% | -17.09% |
Max Drawdown (5Y)Largest decline over 5 years | -40.53% | -19.51% | -21.02% |
Max Drawdown (10Y)Largest decline over 10 years | -90.64% | — | — |
Current DrawdownCurrent decline from peak | -99.61% | -0.45% | -99.16% |
Average DrawdownAverage peak-to-trough decline | -81.88% | -5.84% | -76.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.14% | 2.58% | +19.56% |
Volatility
RXD vs. FTXH - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 10.19% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 5.38%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.19% | 5.38% | +4.81% |
Volatility (6M)Calculated over the trailing 6-month period | 21.87% | 11.96% | +9.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.03% | 17.14% | +12.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.85% | 16.34% | +13.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.00% | 18.43% | +14.57% |
RXD vs. FTXH - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than FTXH's 0.60% expense ratio.
Dividends
RXD vs. FTXH - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 2.69%, more than FTXH's 1.19% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.19% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
RXD ProShares UltraShort Health Care | 2.69% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and FTXH have a correlation of -0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (10.19%) compared to FTXH (5.38%). In terms of maximum drawdown, RXD dropped -99.65% vs FTXH's -32.11%.
On 5-year performance, FTXH leads with 8.33% vs -7.99% for RXD. On fees, FTXH is cheaper at 0.60% per year. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 8.33% return vs -7.99%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FTXH is cheaper with a 0.60% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 2.69%, compared with 1.19% for FTXH.
RXD is categorized as Leveraged Equities, while FTXH is Health & Biotech Equities. RXD tracks DJ Global United States (All) / Health Care -IND (-200%), while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: ProShares and First Trust. Their fees differ too: 0.95% for RXD and 0.60% for FTXH.
FTXH currently has the higher Sharpe Ratio (2.32 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer